Literature DB >> 15722586

Percentile distributions of bone measurements in Iowa children: the Iowa Bone Development Study.

Marcia C Willing1, James C Torner, Trudy L Burns, Kathleen F Janz, Teresa A Marshall, Julie Gilmore, John J Warren, Steven M Levy.   

Abstract

Four hundred twenty-eight white children (200 boys and 228 girls) ages 4.5-6.5 yr had spine, hip, and whole-body bone mineral density (BMD) and bone mineral content (BMC) measured by dual-energy X-ray absorptiometry(DXA) as part of the Iowa Bone Development Study. Anthropometric measurements, including height, weight, and body mass index (BMI) were determined for each child at the time the bone measurements were made. The age- and gender-specific height percentile based on the 2000 CDC Growth Charts (www.cdc.gov/growthcharts/) was determined for each child. These percentiles were used to classify children into four groups as defined by the 25th, 50th,and 75th percentile cutpoints. Percentile distributions were determined within each height quartile group to delineate percentiles (5th, 25th, 50th, 75th, 95th) for BMD and BMC. Gender differences in BMD and BMC were investigated before and after stratification into height groups. Boys had higher age-height-weight-adjusted means for most BMD and BMC measures except spine BMD. Bone measurements increased with height quartile, indicating that taller children have greater BMD and BMC compared to shorter children of the same age and gender. Within any given quartile,mean BMD and BMC measurements were similar for boys and girls, with the exception of hip BMD, for which values were consistently higher for boys (p < 0.05). In addition, whole-body BMC values were higher for boys in quartiles 1 and 3 (p < 0.05). These bone measures provide norms for young white children and serve as a reference for comparison with other racial and ethnic groups, as well as with childhood populations that are at risk for osteopenia because of chronic disease. Gender, age, and height are useful clinical predictors of BMD and BMC in young children.

Entities:  

Mesh:

Year:  2005        PMID: 15722586     DOI: 10.1385/jcd:8:1:039

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.963


  5 in total

Review 1.  The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.

Authors:  C M Weaver; C M Gordon; K F Janz; H J Kalkwarf; J M Lappe; R Lewis; M O'Karma; T C Wallace; B S Zemel
Journal:  Osteoporos Int       Date:  2016-02-08       Impact factor: 4.507

2.  A hip analysis protocol for pediatric bone densitometry: the Iowa Bone Development Study.

Authors:  Julie M Eichenberger Gilmore; Cynthia A Pauley; Trudy L Burns; James C Torner; Elena M Letuchy; Kathleen F Janz; Marcia C Willing; Steven M Levy
Journal:  J Clin Densitom       Date:  2010-09-20       Impact factor: 2.617

3.  Age trends of bone mineral density and percentile curves in healthy Chinese children and adolescents.

Authors:  Bin Guo; Yi Xu; Jian Gong; Yongjin Tang; Hao Xu
Journal:  J Bone Miner Metab       Date:  2013-01-30       Impact factor: 2.626

4.  Associations of fluoride intake with children's bone measures at age 11.

Authors:  Steven M Levy; Julie Eichenberger-Gilmore; John J Warren; Elena Letuchy; Barbara Broffitt; Teresa A Marshall; Trudy Burns; Marcia Willing; Kathleen Janz; James C Torner
Journal:  Community Dent Oral Epidemiol       Date:  2009-10       Impact factor: 3.383

5.  The ability of lumbar spine DXA and phalanx QUS to detect previous fractures in young thalassemic patients with hypogonadism, hypothyroidism, diabetes, and hepatitis-B: A 2-year subgroup analysis from the Taranto Area of Apulia Region.

Authors:  Alberto Argentiero; Cosimo Neglia; Angelo Peluso; Salvatore di Rosa; Antonio Ferrarese; Gianluca Di Tanna; Vincenzo Caiaffa; Marco Benvenuto; Alexandru Cozma; Giovanna Chitano; Nadia Agnello; Daniele Paladini; Nicola Baldi; Alessandro Distante; Prisco Piscitelli
Journal:  J Pediatr Hematol Oncol       Date:  2013-08       Impact factor: 1.289

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.